AIM
BDSI

Alambic Investment Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Alambic Investment Management’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-19,879
Closed -$87K – 181
2020
Q2 		$87K Hold
19,879
– – 0.22% 138
2020
Q1 		$75K Sell
19,879
-99,311
-83% -$488K 0.18% 146
2019
Q4 		$753K Buy
119,190
+73,700
+162% +$433K 0.63% 44
2019
Q3 		$192K Buy
+45,490
New +$194K 0.14% 218

Other funds holding BDSI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Alambic Investment Management's BDSI Position: Q3 2020 in Review

Alambic Investment Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q3 2020, closing a stake of 19,879 shares — an estimated $87K sold.

Alambic Investment Management first reported a position in BDSI in Q3 2019 and held it in 4 quarters. The position peaked at $753K in Q4 2019. 147 funds tracked by Wall St. Rank hold BDSI as of Q3 2020.

  • Alambic Investment Management reported no remaining BioDelivery Sciences International, Inc. position as of Q3 2020 after selling out during the quarter.
  • Alambic Investment Management sold 19,879 BioDelivery Sciences International, Inc. shares in Q3 2020, an estimated $87K.
  • Alambic Investment Management first reported a position in BioDelivery Sciences International, Inc. in Q3 2019 and held it in 4 quarters.
  • Alambic Investment Management's BioDelivery Sciences International, Inc. position peaked at $753K in Q4 2019.
  • 147 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q3 2020.

Based on Alambic Investment Management's 13F filing for Q3 2020, filed 13 Nov 2020.